Physician

Jason Paul Guthrie, M.D

According to 2025 Medicare claims, Jason Guthrie, M.D (NPI: 1437299682) practices rheumatology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SPRINGFIELD CLINIC, LLP (NPI: 1780638478; TIN: 370701328) and primary practice location at 62703-2403. Guthrie is affiliated with the Springfield Clinic ACO, LLC (ACO ID: A2587), IRCCO (ACO ID: A2619), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Guthrie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 107,879 HCPCS/CPT codes, and received $1,462,688 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,364 prescription claims across 453 beneficiaries totaling $3,784,845 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 156 records totaling $8,972. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $591,294 to $3,784,845. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	609	32,983	$1,103,150
2016	605	39,274	$1,248,915
2017	599	47,108	$1,609,337
2018	690	68,766	$2,029,972
2019	674	94,522	$2,539,026
2020	581	87,909	$1,863,657
2021	530	91,546	$1,488,008
2022	557	121,865	$1,412,979
2023	537	101,936	$1,284,626
2024	504	107,879	$1,462,688

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	360	2,856	$591,294
2016	370	2,847	$775,078
2017	356	2,510	$989,871
2018	377	2,650	$1,431,860
2019	385	2,790	$1,567,309
2020	392	2,774	$1,953,323
2021	399	2,666	$2,183,840
2022	405	2,792	$2,621,288
2023	434	2,994	$3,050,470
2024	453	3,364	$3,784,845

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	197	350	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	262	427	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	126	187	$12
96372	Injection of drug or substance under skin or into muscle	103	212	$10
36415	Insertion of needle into vein for collection of blood sample	179	255	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	186	5,820	$1,254,943
Humira(Cf) Pen	Adalimumab	142	4,262	$1,045,053
Enbrel Sureclick	Etanercept	56	1,568	$409,445
Orencia Clickject	Abatacept	27	756	$164,211
Humira Pen	Adalimumab	14	560	$147,463

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$8,972	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason Paul Guthrie, M.D?

Tedicare shows public-source Medicare data for Jason Paul Guthrie, M.D (NPI 1437299682), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Paul Guthrie, M.D have ACO affiliation data?

Jason Paul Guthrie, M.D is shown with ACO affiliation data for Springfield Clinic ACO, LLC (MSSP, ACO ID A2587), IRCCO (MSSP, ACO ID A2619), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jason Paul Guthrie, M.D?

Jason Paul Guthrie, M.D is linked to SPRINGFIELD CLINIC, LLP (billing NPI 1780638478) in the available physician profile data.

Does Jason Paul Guthrie, M.D have Open Payments data?

Jason Paul Guthrie, M.D has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.